Voya Investment Management LLC Has $95.76 Million Holdings in Mettler-Toledo International, Inc. $MTD

Key Points

• Voya Investment Management LLC increased its stake in Mettler-Toledo International by 74.7% during the first quarter, acquiring an additional 34,681 shares, bringing its total holdings to 81,094 shares valued at approximately $95.76 million.
• Insider selling activity included Gerry Keller, who reduced his position by 63.71% after selling 165 shares for approximately $215,926, while CFO Shawn Vadala sold 300 shares for about $397,500.
• Mettler-Toledo International recently reported $10.09 EPS for the last quarter, exceeding analysts' expectations, and has set FY 2025 EPS guidance between $42.100 and $42.600.

Voya Investment Management LLC grew its holdings in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 74.7% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 81,094 shares of the medical instruments supplier's stock after purchasing an additional 34,681 shares during the period. Voya Investment Management LLC owned about 0.39% of Mettler-Toledo International worth $95,764,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Inspire Investing LLC raised its holdings in shares of Mettler-Toledo International by 8.6% in the first quarter. Inspire Investing LLC now owns 2,235 shares of the medical instruments supplier's stock valued at $2,639,000 after purchasing an additional 177 shares during the last quarter. Modern Wealth Management LLC bought a new stake in shares of Mettler-Toledo International during the 1st quarter worth approximately $325,000. Acadian Asset Management LLC raised its stake in shares of Mettler-Toledo International by 84.9% during the 1st quarter. Acadian Asset Management LLC now owns 2,513 shares of the medical instruments supplier's stock worth $2,965,000 after purchasing an additional 1,154 shares in the last quarter. Geneos Wealth Management Inc. raised its stake in shares of Mettler-Toledo International by 83.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier's stock worth $78,000 after purchasing an additional 30 shares in the last quarter. Finally, Focus Partners Wealth raised its stake in shares of Mettler-Toledo International by 85.6% during the 1st quarter. Focus Partners Wealth now owns 3,195 shares of the medical instruments supplier's stock worth $3,774,000 after purchasing an additional 1,474 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

MTD has been the topic of a number of analyst reports. Bank of America upped their price objective on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a research note on Thursday, June 26th. Citigroup upped their price objective on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a research note on Thursday, August 21st. Evercore ISI dropped their price objective on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating on the stock in a research note on Monday, August 4th. Barclays began coverage on Mettler-Toledo International in a research note on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 price target on the stock. Finally, UBS Group upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and dropped their price target for the company from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $1,311.11.

Insider Buying and Selling at Mettler-Toledo International

In other news, insider Gerry Keller sold 165 shares of the stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the sale, the insider directly owned 94 shares of the company's stock, valued at approximately $123,012.16. This represents a 63.71% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Shawn Vadala sold 300 shares of the stock in a transaction on Friday, August 8th. The stock was sold at an average price of $1,254.09, for a total value of $376,227.00. Following the sale, the chief financial officer directly owned 5,095 shares in the company, valued at approximately $6,389,588.55. This trade represents a 5.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 1,827 shares of company stock valued at $2,371,208 in the last ninety days. 0.77% of the stock is currently owned by corporate insiders.

Mettler-Toledo International Price Performance

NYSE MTD traded up $2.68 on Monday, reaching $1,262.22. The stock had a trading volume of 109,653 shares, compared to its average volume of 118,112. The firm has a fifty day moving average of $1,260.42 and a two-hundred day moving average of $1,184.76. Mettler-Toledo International, Inc. has a 1-year low of $946.69 and a 1-year high of $1,521.01. The company has a market cap of $26.00 billion, a P/E ratio of 31.96, a price-to-earnings-growth ratio of 3.78 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating analysts' consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The firm had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. During the same period in the prior year, the firm posted $9.65 EPS. The company's revenue for the quarter was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Research analysts predict that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.